Literature DB >> 17049665

Relationship between high-sensitivity C-reactive protein levels and liver histology in subjects with non-alcoholic fatty liver disease.

Giovanni Targher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17049665     DOI： 10.1016/j.jhep.2006.09.005

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  31 in total

1.  Atherogenic dyslipidemia and cardiovascular risk in children with nonalcoholic fatty liver disease.

Authors:  Naim Alkhouri; Christine Carter-Kent; Michael Elias; Ariel E Feldstein
Journal:  Clin Lipidol       Date:  2011-06-01

Review 2.  Noninvasive biomarkers in non-alcoholic fatty liver disease: current status and a glimpse of the future.

Authors:  Emer Fitzpatrick; Anil Dhawan
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

3.  Do Genetic Markers of Inflammation Modify the Relationship between Periodontitis and Nonalcoholic Fatty Liver Disease? Findings from the SHIP Study.

Authors:  A A Akinkugbe; C L Avery; A S Barritt; S R Cole; M Lerch; J Mayerle; S Offenbacher; A Petersmann; M Nauck; H Völzke; G D Slade; G Heiss; T Kocher; B Holtfreter
Journal:  J Dent Res       Date:  2017-07-21       Impact factor: 6.116

4.  Clinical significance of hepatic steatosis according to coronary plaque morphology: assessment using controlled attenuation parameter.

Authors:  Hyo Eun Park; Heesun Lee; Su-Yeon Choi; Min-Sun Kwak; Jong In Yang; Jeong Yoon Yim; Goh Eun Chung
Journal:  J Gastroenterol       Date:  2018-10-04       Impact factor: 7.527

5.  Prevalence of nonalcoholic fatty liver disease (NAFLD) in patients of cardiovascular diseases and its association with hs-CRP and TNF-α.

Authors:  Masihur Rehman Ajmal; Monika Yaccha; Mohammed Azharuddin Malik; M U Rabbani; Ibne Ahmad; Najmul Isalm; Nasar Abdali
Journal:  Indian Heart J       Date:  2014-08-28

6.  Does vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease? A randomized clinical trial.

Authors:  Nasrin Sharifi; Reza Amani; Eskandar Hajiani; Bahman Cheraghian
Journal:  Endocrine       Date:  2014-06-27       Impact factor: 3.633

Review 7.  Extra-Hepatic Manifestations of Nonalcoholic Fatty Liver Disease: A Review.

Authors:  Raseen Tariq; Page Axley; Ashwani K Singal
Journal:  J Clin Exp Hepatol       Date:  2019-07-25

8.  The association of nonalcoholic fatty liver disease, obesity, and metabolic syndrome, with systemic inflammation and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Mahmoud Al Rifai; Michael G Silverman; Khurram Nasir; Matthew J Budoff; Ron Blankstein; Moyses Szklo; Ronit Katz; Roger S Blumenthal; Michael J Blaha
Journal:  Atherosclerosis       Date:  2015-02-07       Impact factor: 5.162

9.  Increased risk of CKD among type 2 diabetics with nonalcoholic fatty liver disease.

Authors:  Giovanni Targher; Michel Chonchol; Lorenzo Bertolini; Stefano Rodella; Luciano Zenari; Giuseppe Lippi; Massimo Franchini; Giacomo Zoppini; Michele Muggeo
Journal:  J Am Soc Nephrol       Date:  2008-04-02       Impact factor: 10.121

10.  The inflamed liver and atherosclerosis: a link between histologic severity of nonalcoholic fatty liver disease and increased cardiovascular risk.

Authors:  Naim Alkhouri; Tarek Abu-Rajab Tamimi; Lisa Yerian; Rocio Lopez; Nizar N Zein; Ariel E Feldstein
Journal:  Dig Dis Sci       Date:  2009-12-05       Impact factor: 3.199
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.